# Washington Hospital Center Transfusion Service – FDA Inspection, Sep 20, 2022

Source: https://www.keypedia.com/records/fda_inspections/washington-hospital-center-transfusion-service/54056fa0-4105-453d-bc5b-23e16a0595dd
Source feed: FDA_Inspections

> FDA inspection 1181203 of Washington Hospital Center Transfusion Service, September 20, 2022. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181203
- Company Name: Washington Hospital Center Transfusion Service
- Inspection Date: 2022-09-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1224426 - 2023-11-16
- [FDA Inspection 1047535 - 2018-04-06](https://www.keypedia.com/records/fda_inspections/washington-hospital-center-transfusion-service/3985fef5-b2c3-4771-920f-5c5ddf1cafe5)
- FDA Inspection 964119 - 2016-03-08
- FDA Inspection 887633 - 2014-06-24
- FDA Inspection 816379 - 2013-01-28

Company: https://www.keypedia.com/companies/washington-hospital-center-transfusion-service/feef901f-d9bd-40b4-a275-9dbe49603d7d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d